Results 141 to 150 of about 5,356 (175)

Edaravone/riluzole

Reactions Weekly, 2022
openaire   +1 more source

Advantages of edaravone dextrosanol in elderly patients with acute cerebral infarction versus edaravone: a preliminary study

International Journal of Neuroscience
To analyze and compare the application advantages of Edaravone and Edaravone Dextrosanol in elderly patients with acute cerebral infarction (ACI).A retrospective analysis of clinical data from 113 elderly AIS patients admitted to our hospital between January 2022 and January 2023 was conducted.
Xiaofeng, Zhu, Qiang, Jin, Xiaojing, Liu
openaire   +2 more sources

Ocrelizumab, edaravone, and valbenazine

Journal of the American Pharmacists Association, 2017
Daniel A, Hussar, Terra L, Hussar
openaire   +2 more sources

Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke

Stroke, 2021
Jun Xu, Huaguang Zheng
exaly  

[Edaravone].

Nihon rinsho. Japanese journal of clinical medicine, 2007
openaire   +3 more sources

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis

Pharmaceuticals, 2021
Surabhi Shukla
exaly  

Edaravone Mitsubishi-Tokyo.

Current opinion in investigational drugs (London, England : 2000), 2001
Mitsubishi-Tokyo (formerly Mitsubishi Chemical) is developing edaravone (norphenazone), a free radical scavenger, for the potential treatment of cardiovascular disease, cerebrovascular ischemia and cerebral edema. By February 2000, edaravone had been filed in Japan for the treatment of acute brain infarction, and was in phase III trials for ...
openaire   +1 more source

Bosentan/cilostazol/edaravone

Reactions Weekly, 2021
openaire   +1 more source

Cefazolin/edaravone/iohexol

Reactions Weekly, 2021
openaire   +1 more source

Edaravone dosage form

2021
ZHOU XINFU, PARIKH ANKIT, GARG SANJAY
openaire   +2 more sources